The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

ResMed Inc

NYSE: RMD
Last

(U.S.) $56.06

Today's change+1.11 +2.02%
Updated December 18 2:27 PM EST. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $56.06

Today's change+1.11 +2.02%
Updated December 18 2:27 PM EST. Delayed by at least 15 minutes.

ResMed Inc Hits New 100-day High

ResMed Inc is up sharply today, rallying (U.S.)$1.11 or 2.02% to (U.S.)$56.06 and setting a new 100-day high. Over the last five days, shares have gained 4.61% and 19.07% year to date. Shares have outperformed the S&P 500 by 9.54% during the last year.

Key company metrics

  • Open(U.S.) $55.12
  • Previous close(U.S.) $54.95
  • High(U.S.) $56.42
  • Low(U.S.) $55.03
  • Bid / Ask(U.S.) $56.06 / (U.S.) $56.07
  • YTD % change+19.07%
  • Volume758,014
  • Average volume (10-day)1,100,339
  • Average volume (1-month)884,657
  • Average volume (3-month)1,026,158
  • 52-week range(U.S.) $41.52 to (U.S.) $56.42
  • Beta0.85
  • Trailing P/E23.06×
  • P/E 1 year forward21.40×
  • Forward PEG1.74×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield2.00%
  • Trailing EPS(U.S.) $2.43
Updated December 18 2:27 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+22.03%

Based on its net profit margin of 22.03%, ResMed Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.47%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue380415398384
Total other revenue--------
Total revenue380415398384
Gross profit237261252249
Total cost of revenue143154146136
Total operating expense286317293279
Selling / general / administrative111122115112
Research & development30323030
Depreciation / amortization2222
Interest expense (income), net operating--------
Unusual expense (income)--6----
Other operating expenses, total--------
Operating income9598105105
Interest income (expense), net non-operating---6----
Gain (loss) on sale of assets--------
Other--------
Income before tax102107113109
Income after tax83889087
Income tax, total19192323
Net income83889087
Total adjustments to net income--------
Net income before extra. items83889087
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items83889087
Inc. avail. to common incl. extra. items83889087
Diluted net income83889087
Dilution adjustment----00
Diluted weighted average shares143143143145
Diluted EPS excluding extraordinary itemsvalue per share0.580.610.630.60
Dividends per sharevalue per share0.280.250.250.25
Diluted normalized EPSvalue per share0.580.650.630.60